Related Experiment Videos
Alcoholic hepatitis: from pathogenesis to treatment.
S Sougioultzis1, E Dalakas, P C Hayes
1Department of Hepatology, The Royal Infirmary of Edinburgh and University of Edinburgh, UK.
Current Medical Research and Opinion
|October 4, 2005
Summary
Alcoholic hepatitis, a severe liver condition from alcohol abuse, has high mortality. While corticosteroids show mixed results, TNF-alpha inhibition offers a promising new treatment avenue.
Area of Science:
- Hepatology and Gastroenterology
- Immunology and Inflammation
Background:
- Alcoholic hepatitis is a critical complication of alcohol abuse, characterized by high short-term mortality.
- It can develop in patients with pre-existing alcoholic fatty liver or cirrhosis.
- Cytokines and immune responses are increasingly recognized as key players in its pathogenesis.
Purpose of the Study:
- To summarize the current diagnostic and management strategies for alcoholic hepatitis.
- To review recent advances in understanding the pathophysiology of alcoholic hepatitis.
- To explore potential new therapeutic targets for this challenging liver condition.
Main Methods:
- Comprehensive literature search of Medline, EMBASE/Excerpta Medica, and The Cochrane Library (1966-2005).
- Inclusion of data from published reports and direct contact with authors.
Main Results:
- Diagnosis is primarily based on clinical and laboratory findings, with liver biopsy used selectively.
- Current management focuses on abstinence and supportive care.
- Corticosteroid treatment has yielded conflicting results in clinical trials.
- Emerging evidence suggests TNF-alpha inhibition as a potentially beneficial therapeutic approach.
Conclusions:
- Alcoholic hepatitis requires prompt diagnosis and management due to its severity.
- While traditional treatments have limitations, novel strategies targeting inflammatory pathways show promise.
- Further research into the pathophysiology may uncover new therapeutic avenues for alcoholic hepatitis.